EUDA Health Holdings Income from Continuous Operations 2022-2024 | EUDA

EUDA Health Holdings income from continuous operations from 2022 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
EUDA Health Holdings Annual Income from Continuous Operations
(Millions of US $)
2024 $-18
2023 $-8
2022 $-25
2021 $1
EUDA Health Holdings Quarterly Income from Continuous Operations
(Millions of US $)
2024-06-30
2023-12-31
2023-03-31 $-2
2022-12-31
2022-03-31 $0
2021-12-31
2021-10-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.126B $0.004B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.456B 59.10
Doximity (DOCS) United States $11.587B 53.64
Hims & Hers Health (HIMS) United States $10.739B 111.58
Tempus AI (TEM) United States $10.555B 0.00
IRhythm Technologies (IRTC) United States $4.548B 0.00
Inspire Medical Systems (INSP) United States $3.789B 59.21
Hinge Health (HNGE) United States $3.638B 0.00
Privia Health (PRVA) United States $2.696B 184.25
Enovis (ENOV) United States $1.922B 10.72
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.602B 0.00
Schrodinger (SDGR) United States $1.550B 0.00
Azenta (AZTA) United States $1.521B 70.70
Omnicell (OMCL) United States $1.398B 24.66
Evolent Health (EVH) United States $1.384B 117.90
Clover Health Investments (CLOV) United States $1.303B 0.00
Claritev (CTEV) United States $0.747B 0.00
Fulgent Genetics (FLGT) United States $0.611B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.513B 0.00
Butterfly Network (BFLY) United States $0.480B 0.00
Talkspace (TALK) United States $0.463B 138.50
Outset Medical (OM) United States $0.370B 0.00
TruBridge (TBRG) United States $0.343B 761.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.167B 0.00
American Well (AMWL) United States $0.133B 0.00
Pulmonx (LUNG) United States $0.112B 0.00
CareCloud (CCLD) United States $0.104B 3.97
MDxHealth SA (MDXH) Belgium $0.104B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
111 (YI) China $0.064B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.060B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.044B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00